OrbiMed’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
+51,727
| New | +$457K | 0.01% | 94 |
|
|
2025
Q1 | – | Sell |
-155,181
| Closed | -$1.99M | – | 111 |
|
|
2024
Q4 | $1.99M | Sell |
155,181
-149,119
| -49% | -$1.91M | 0.04% | 96 |
|
|
2024
Q3 | $8.4M | Sell |
304,300
-15,955
| -5% | -$440K | 0.15% | 82 |
|
|
2024
Q2 | $9.29M | Buy |
320,255
+310,280
| +3,111% | +$9M | 0.18% | 75 |
|
|
2024
Q1 | $445K | Buy |
+9,975
| New | +$445K | 0.01% | 110 |
|